IRIS
PASSINO, Claudio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 51.891
EU - Europa 32.402
AS - Asia 26.404
SA - Sud America 5.379
AF - Africa 657
OC - Oceania 140
Continente sconosciuto - Info sul continente non disponibili 110
Totale 116.983
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 48.973
SG - Singapore 9.635
GB - Regno Unito 7.253
RU - Federazione Russa 7.236
IT - Italia 6.756
CN - Cina 6.591
BR - Brasile 4.200
VN - Vietnam 3.649
UA - Ucraina 2.331
DE - Germania 2.306
CA - Canada 2.221
HK - Hong Kong 1.964
BD - Bangladesh 1.651
DK - Danimarca 1.529
FR - Francia 1.115
FI - Finlandia 840
SE - Svezia 819
IN - India 566
IE - Irlanda 549
PL - Polonia 535
MX - Messico 474
AR - Argentina 434
NL - Olanda 379
TR - Turchia 327
IL - Israele 279
ID - Indonesia 248
EC - Ecuador 215
IQ - Iraq 214
ZA - Sudafrica 212
PK - Pakistan 209
JP - Giappone 204
ES - Italia 184
CO - Colombia 137
AT - Austria 114
VE - Venezuela 112
EU - Europa 106
AU - Australia 104
UZ - Uzbekistan 100
MA - Marocco 99
SA - Arabia Saudita 90
CL - Cile 86
KR - Corea 76
AE - Emirati Arabi Uniti 69
PY - Paraguay 67
IR - Iran 66
KE - Kenya 64
MY - Malesia 63
LT - Lituania 62
EG - Egitto 61
PH - Filippine 61
PE - Perù 55
TN - Tunisia 52
RO - Romania 48
JO - Giordania 46
CH - Svizzera 41
DZ - Algeria 41
BE - Belgio 39
NP - Nepal 38
CR - Costa Rica 37
JM - Giamaica 34
BO - Bolivia 33
NZ - Nuova Zelanda 33
UY - Uruguay 33
SK - Slovacchia (Repubblica Slovacca) 32
AZ - Azerbaigian 31
CZ - Repubblica Ceca 30
ET - Etiopia 30
TH - Thailandia 30
HN - Honduras 29
PT - Portogallo 27
KZ - Kazakistan 23
TW - Taiwan 22
GR - Grecia 21
DO - Repubblica Dominicana 19
TT - Trinidad e Tobago 19
KG - Kirghizistan 18
PS - Palestinian Territory 17
AL - Albania 16
OM - Oman 16
HU - Ungheria 15
NI - Nicaragua 15
PA - Panama 15
QA - Qatar 15
GE - Georgia 13
GT - Guatemala 13
AM - Armenia 12
LV - Lettonia 12
RS - Serbia 12
BY - Bielorussia 11
NO - Norvegia 11
SN - Senegal 11
BG - Bulgaria 10
BH - Bahrain 10
CI - Costa d'Avorio 10
KW - Kuwait 10
LB - Libano 10
MK - Macedonia 10
BA - Bosnia-Erzegovina 9
HR - Croazia 9
MD - Moldavia 9
Totale 116.787
Salva come PNG Salva come JPEG
Città #
Dallas 8.059
Southend 4.837
Singapore 4.817
San Jose 3.007
Ashburn 2.977
Beijing 2.740
Woodbridge 2.675
Chandler 2.320
Ann Arbor 2.295
Houston 2.108
Hong Kong 1.745
Fairfield 1.626
San Mateo 1.470
Moscow 1.304
Falls Church 1.263
Jacksonville 1.107
Seattle 1.093
Los Angeles 1.052
Dearborn 1.020
Ho Chi Minh City 995
Cambridge 967
Milan 944
Wilmington 895
Ottawa 865
The Dalles 794
New York 750
Chicago 652
Pisa 645
Rome 637
Hanoi 627
Hefei 542
Boardman 538
Dublin 522
Santa Clara 517
Lauterbourg 513
Stevenage 512
Portsmouth 502
Warsaw 491
Dong Ket 483
São Paulo 440
Buffalo 435
Helsinki 426
Montréal 403
Lawrence 385
Council Bluffs 358
Brooklyn 320
Beauharnois 315
London 257
Tel Aviv 251
Munich 247
Orem 244
Salt Lake City 229
Mexico City 212
Montreal 203
Florence 200
Frankfurt am Main 181
San Diego 176
Redwood City 175
Tokyo 165
Old Bridge 158
Denver 155
Stockholm 152
Chennai 150
Columbus 149
Istanbul 148
Rio de Janeiro 144
Toronto 144
Atlanta 141
Poplar 141
Amsterdam 134
Da Nang 134
Figino 134
Johannesburg 134
Phoenix 127
Haiphong 120
Tampa 114
Elk Grove Village 112
Fremont 111
Boston 109
Nuremberg 108
Naples 99
Turin 99
Manchester 95
Tashkent 90
Bologna 89
San Francisco 88
Ankara 78
Biên Hòa 74
Mumbai 73
Belo Horizonte 72
Washington 72
Brasília 71
Curitiba 71
Turku 69
Baghdad 68
Norwalk 68
Guayaquil 67
Shanghai 67
Paris 66
Quito 65
Totale 70.888
Salva come PNG Salva come JPEG
Nome #
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.703
Value in Healthcare and the Role of the Patient Voice 1.202
Valutazione delle caratteristiche analitiche e dei risultati clinici di un metodo in chemiluminescenza a cattura di microparticelle (CMIA) per il dosaggio della Galectina-3 sulla piattaforma ARCHITECT 696
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 615
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 595
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 506
E-Health in Tuscany Inner Areas: The PROXIMITY-CARE Approach 499
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 486
Impact of GFR Estimation Formulas on MECKI Score Performance and Prognostic Accuracy in Heart Failure: The MECKI-RENAL Study 480
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 450
[The use of PROMs (patient-reported outcome measures) and PREMs (patient-reported experience measures) in Cardiology: current state and applications to improve patient care] 435
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. 415
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure 397
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 391
A simple echocardiographic score to rule out cardiac amyloidosis 387
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liverdisease. 381
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 368
Human pathophysiological adaptations to the space environment 361
Grapevine microRNAs in an in vitro model of cell line: new potential insight on their role in the setting of human health. 359
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 356
A simple echocardiographic score to rule out cardiac amyloidosis 354
Functional ancient grain bread rich in iron, zinc, flavonoids and alpha lipoic acid attenuates post-ischemic myocardial remodeling in rats 354
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 348
"To Breathe, or Not to Breathe: That Is the Question" in "The Breathless Heart: Apneas in Heart Failure" 344
La neuropatia diabetica 342
A role for gamma-glutamyltransferase in pathogenesis and evolution of cardiovascular diseases. 336
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 334
[Central apneas and cardiovascular diseases] 333
An open computational toolbox to analyze multi- and single-unit sympathetic nerve activity in microneurography 332
Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: some results. 331
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 331
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 330
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 330
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 330
The evolution of TAVI performance overtime: an overview of systematic reviews 328
Tuscany Sangiovese Grape juice imparts cardioprotection by regulating gene expression of Cardioprotective C-Type Natriuretic Peptide. 328
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 326
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 325
N-terminal fragment of B-type natriuretic peptide predicts coexisting subclinical heart and vessel disease 325
Treating chemoreflex in heart failure: modulation or demolition? 324
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data 324
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 324
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 324
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 323
Prediction of the chemoreflex gain by common clinical variables in heart failure 323
Evaluation of analytical performance of a new high-sensitivity immunoassay for cardiac troponin i 323
A longitudinal assessment of chronic care pathways in real-life: self-care and outcomes of chronic heart failure patients in Tuscany 322
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 319
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals 315
Natriuretic peptides expression in a murine model of myocardial infarction after Sangiovese grape juice intake. Focus on CNP and ON putative involvement of plant miRNAs in-vitro and in healthy humans 315
Ancient grain bread rich in iron, zinc, flavonoids and alpha lipoic acid as a novel preoperative functional food for suppressing the progression of cardiovascular remodeling in infarcted male rats 314
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 314
Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? 314
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 313
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 311
Adrenergic activation in heart failure: blockade or rebalance? 309
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. 309
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis 307
Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy 306
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 304
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 303
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives 303
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 303
Biomarcatori di stabilità della placca aterosclerotica (Rassegna) 302
Sex Profile and Risk Assessment With Cardiopulmonary Exercise Testing in Heart Failure: Propensity Score Matching for Sex Selection Bias 302
Evaluation of analytical performance and comparison of clinical results of the new generation method AccuTnI+3 for the measurement of cardiac troponin I using both patients and quality control plasma samples 301
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 300
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? 299
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 298
Eligibility for vericiguat in a real‐world, contemporary heart failure population 297
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 297
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 296
Acute right-sided transcutaneous vagus nerve stimulation improves cardio-vagal baroreflex gain in patients with chronic heart failure 296
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 295
Influence of preload and afterload on stroke volume response to low-dose dobutamine stress in patients with non-ischemic heart failure: A cardiac MR study 295
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 293
Evaluation of analytical performance of a novel immunoenzymometric assay for cTnI. 290
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 290
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 290
Screening the health status of people working in a university 289
AEROBIC TRAINING DECREASES AORTIC STIFFNESS IN PATIENTS WITH HEART FAILURE 289
Bioinformatics analysis of the gene profile of coronary endothelial cells treated with Grapevine microRNAs: an in vitro study 289
Acute and persistent effects of a 46-kilometer wilderness trail run at altitude: cardiovascular autonomic modulation and baroreflexes. 287
Renal denervation in resistant arterial hypertension: Effects on neurohormonal activation and cardiac natriuretic peptides 286
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 286
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 286
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 285
Usefulness of high-sensitive troponin elevation after effort stress to unveil vulnerable myocardium in patients with hart failure 285
A matter of sex—persistent predictive value of MECKI score prognostic power in men and women with heart failure and reduced ejection fraction: a multicenter study 284
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 284
Metabolic exercise data combined with cardiac and kidney indexes: MECKI score. Predictive role in cardiopulmonary exercise testing with low respiratory exchange ratio in heart failure 284
Cardiac biomarker testing in the clinical laboratory:Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides. 283
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 282
How to take arms against central apneas in heart failure 281
Sympathetic and Vagal Nerve Activity in COPD: Pathophysiology, Presumed Determinants and Underappreciated Therapeutic Potential 280
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: New challenges and perspectives 280
Sex-related differences in chronic heart failure 280
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 279
Prognostic value of reverse remodelling criteria in heart failure with reduced or mid-range ejection fraction 278
Cheyne-Stokes respiration related oscillations in cardiopulmonary hemodynamics in patients with heart failure 277
Totale 35.684
Salva come PNG Salva come JPEG
Categoria #
all - tutte 573.324
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 573.324
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.353 0 0 0 0 0 0 0 0 0 0 0 1.353
2021/20226.927 477 1.282 379 663 153 119 764 1.269 561 670 114 476
2022/20235.337 402 312 276 790 779 826 53 432 917 106 244 200
2023/20243.247 292 112 528 227 210 337 303 190 191 167 168 522
2024/202521.093 192 234 1.198 489 999 1.286 2.826 5.165 1.700 1.412 3.316 2.276
2025/202650.834 2.676 8.082 5.678 6.166 5.331 3.021 5.769 2.122 2.720 3.260 3.163 2.846
Totale 117.644